Pet Medications and Treatments: Types, Safety, and Administration

Pet medications span a wide and sometimes surprising range — from the flea preventive applied between a dog's shoulder blades every 30 days to the chemotherapy protocol managing a cat's lymphoma. This page covers the major categories of veterinary pharmaceuticals and treatments, how they work in an animal's body, the scenarios where they're most commonly prescribed, and the critical decision points that separate safe administration from serious harm.

Definition and scope

Veterinary medications are pharmaceutical compounds formulated, approved, or adapted for use in non-human animals to prevent, treat, or manage disease, parasites, pain, infection, or chronic conditions. The U.S. Food and Drug Administration's Center for Veterinary Medicine (FDA-CVM) oversees approval of animal drugs under the Federal Food, Drug, and Cosmetic Act, and as of the FDA's published drug index, over 1,200 animal drug products hold active approved status.

The scope is broader than most pet owners expect. Treatments include:

• Prescription pharmaceuticals — antibiotics, anti-inflammatories, antifungals, antiparasitics, cardiac drugs, hormonal therapies
• Over-the-counter (OTC) products — certain flea and tick preventives, antacids, wound care products
• Extra-label use drugs — human-approved medications used in animals under veterinary supervision, a practice explicitly permitted by the Animal Medicinal Drug Use Clarification Act of 1994 (AMDUCA)
• Compounded medications — custom-formulated drugs prepared by a licensed compounding pharmacy, often used when a commercial product isn't available in the right dose or formulation for a small or exotic animal
• Biologics — vaccines, immunotherapies, and blood products regulated separately under the USDA's Center for Veterinary Biologics

Pet parasite prevention alone accounts for a significant subset of these categories, with products spanning three delivery mechanisms: topical, oral, and injectable.

How it works

Drug action in animals follows the same four pharmacokinetic phases as in humans — absorption, distribution, metabolism, and excretion — but the specific parameters differ dramatically between species. A dog metabolizes certain drugs through cytochrome P450 liver enzymes at a rate roughly comparable to humans. Cats, however, are markedly deficient in glucuronidation pathways, a metabolic process handled by the enzyme UGT1A6. This is why acetaminophen — safe for humans at standard doses — is acutely toxic to cats at even small amounts, and why ibuprofen can cause renal failure in dogs.

Body weight is a reliable dosing reference for many drugs, but it isn't universal. Heartworm preventives like ivermectin and milbemycin are dosed in micrograms per kilogram. NSAIDs like meloxicam are typically dosed at 0.1 mg/kg for dogs on the first day, then 0.05 mg/kg for maintenance — a precision that matters because the therapeutic window and the toxic dose sit uncomfortably close together.

Route of administration shapes both speed and reliability of effect:

1. Oral (PO) — Most common for home administration; absorption varies with stomach contents and formulation
2. Topical — Used for dermatological conditions and systemic antiparasitic delivery; absorption through skin differs by product and species
3. Injectable (IV, IM, SQ) — Fastest onset; typically clinic-administered except for insulin, which many owners are trained to give subcutaneously at home
4. Transdermal gels — Applied to the ear pinna; frequently used for cats resistant to oral dosing; absorption is less predictable than oral routes
5. Ophthalmic and otic — Localized delivery to eyes and ears; systemic absorption is generally minimal but not zero

Common scenarios

The most frequently medicated conditions in companion animals, based on claims data published by the North American Pet Health Insurance Association (NAPHIA), include skin conditions, ear infections, urinary tract infections, gastrointestinal disorders, and osteoarthritis. Each presents a distinct medication profile.

Chronic pain management in dogs with osteoarthritis typically involves NSAIDs as the first-line pharmacological tool, often alongside newer options. Librela (bedinvetmab), an anti-nerve growth factor monoclonal antibody approved by the FDA in 2023 for canine osteoarthritis pain, represents a category shift — a monthly injectable biologic rather than a daily pill.

Anxiety and behavioral conditions in dogs and cats are increasingly treated with FDA-approved veterinary drugs. Reconcile (fluoxetine) and Clomicalm (clomipramine) both hold canine approval; Sileo (dexmedetomidine oromucosal gel) is approved specifically for noise aversion in dogs. This connects directly to the broader landscape of pet mental health and enrichment, where pharmacological intervention is one component of a multi-modal approach.

Ear infections — otitis externa — are often treated with combination otic products containing an antibiotic, an antifungal, and a corticosteroid in a single formulation, which illustrates how veterinary products frequently bundle mechanisms that human medicine would dispense separately.

Decision boundaries

The line between safe and unsafe use of pet medications is drawn at three recurring points.

Species appropriateness is non-negotiable. Permethrin-based topical flea treatments — safe and effective for dogs — are lethal to cats. Tea tree oil, found in some OTC grooming products, causes neurological toxicity in cats and small dogs. The ASPCA Animal Poison Control Center (ASPCA APCC) handled over 401,000 cases in 2021, with over-the-counter human and animal medications ranking among the top toxin categories.

Prescription requirements exist for a reason. Antibiotics requiring a veterinary prescription cannot legally be dispensed without a valid veterinarian-client-patient relationship (VCPR), as defined by FDA regulations at 21 CFR Part 530. Self-treating a suspected bacterial infection with leftover amoxicillin is problematic on two fronts: dosing precision and the risk of masking a misidentified condition.

Drug interactions become critical in senior animals on multiple medications. A dog managed for both hypothyroidism and epilepsy, for instance, requires careful monitoring because phenobarbital affects the metabolism of thyroid hormone. Senior pet care protocols frequently involve the most complex medication regimens, and periodic bloodwork to monitor organ function is standard practice for pets on long-term pharmaceuticals.

For the full context of how medications fit within routine and preventive health practices, the National Pet Care Authority home covers the broader landscape of companion animal care across species and life stages.